Pediatric Endocrinology

[1]  B. Keevil,et al.  Endogenous glucocorticoid analysis by liquid chromatography–tandem mass spectrometry in routine clinical laboratories , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Yiping Shen,et al.  Next-generation sequencing analysis of DUOX2 in 192 Chinese subclinical congenital hypothyroidism (SCH) and CH patients. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[3]  A. Ferrari,et al.  Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients , 2016, Journal of Endocrinological Investigation.

[4]  E. Turkbey,et al.  Use of 3-Dimensional Volumetric Modeling of Adrenal Gland Size in Patients with Primary Pigmented Nodular Adrenocortical Disease , 2016, Hormone and Metabolic Research.

[5]  C. Stratakis,et al.  A genetic and molecular update on adrenocortical causes of Cushing syndrome , 2016, Nature Reviews Endocrinology.

[6]  F. Faucz,et al.  Kidney Stones as an Underrecognized Clinical Sign in Pediatric Cushing Disease. , 2016, The Journal of pediatrics.

[7]  Zhi-Hai Peng,et al.  Could Tumor Size Be A Predictor for Papillary Thyroid Microcarcinoma: a Retrospective Cohort Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[8]  Kyoung-Jin Park,et al.  DUOX2 Mutations Are Frequently Associated With Congenital Hypothyroidism in the Korean Population , 2015, Annals of laboratory medicine.

[9]  M. Pelizzo,et al.  Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience , 2015, American journal of clinical oncology.

[10]  B. Widemann,et al.  Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.

[11]  T. Mazzuchi,et al.  Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome. , 2015, The Journal of clinical endocrinology and metabolism.

[12]  R. Shore,et al.  The Use of 123I in Diagnostic Radioactive Iodine Scans in Children with Differentiated Thyroid Carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  S. Rivkees,et al.  C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain. , 2015, Human pathology.

[14]  G. Vitale,et al.  Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review. , 2015, The Journal of clinical endocrinology and metabolism.

[15]  C. Stratakis,et al.  A gender‐dependent analysis of Cushing's disease in childhood: pre‐ and postoperative follow‐up , 2015, Clinical endocrinology.

[16]  L. Morris,et al.  Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer. , 2015, Thyroid : official journal of the American Thyroid Association.

[17]  J. Lupski,et al.  Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. , 2015, European journal of endocrinology.

[18]  P. Vitti,et al.  Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer? , 2015, Clinical endocrinology.

[19]  M. Komada,et al.  The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. , 2015, The Journal of clinical endocrinology and metabolism.

[20]  C. Stratakis,et al.  Death in pediatric Cushing syndrome is uncommon but still occurs , 2015, European Journal of Pediatrics.

[21]  Sung-Bae Kim,et al.  Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. , 2015, The New England journal of medicine.

[22]  M. Alevizaki,et al.  Papillary thyroid carcinomas in patients under 21 years of age: clinical and histologic characteristics of tumors ≤10 mm. , 2015, The Journal of pediatrics.

[23]  A. Ganti,et al.  Treatment of advanced thyroid cancer: role of molecularly targeted therapies , 2015, Targeted Oncology.

[24]  Ming-Kai Chen,et al.  What is the role of dosimetry in patients with advanced thyroid cancer? , 2015, Current opinion in oncology.

[25]  T. Wieland,et al.  Mutations in the deubiquitinase gene USP8 cause Cushing's disease , 2014, Nature Genetics.

[26]  F. Worden.  Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer , 2014, Therapeutic advances in medical oncology.

[27]  J. Schopohl,et al.  Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study , 2014, Clinical endocrinology.

[28]  L. Buchmann,et al.  BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma , 2014, The Laryngoscope.

[29]  K. Kuhn,et al.  Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease. , 2014, European journal of endocrinology.

[30]  P. Grigsby,et al.  BRAF V600E mutational status in pediatric thyroid cancer , 2014, Pediatric blood & cancer.

[31]  Jeffrey E. Lee,et al.  Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. , 2014, Thyroid : official journal of the American Thyroid Association.

[32]  Sang-Man Jin,et al.  The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment. , 2014, Thyroid : official journal of the American Thyroid Association.

[33]  J. Newell-Price.  Ketoconazole as an adrenal steroidogenesis inhibitor: effectiveness and risks in the treatment of Cushing's disease. , 2014, The Journal of clinical endocrinology and metabolism.

[34]  J. Varhaug,et al.  Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B: A Changing Perspective , 2014, Annals of surgery.

[35]  T. Wieland,et al.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. , 2014, The New England journal of medicine.

[36]  F. Faucz,et al.  Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. , 2014, The Journal of clinical endocrinology and metabolism.

[37]  E. Mirallié,et al.  Role of Preoperative Basal Calcitonin Levels in the Timing of Prophylactic Thyroidectomy in Patients With Germline RET Mutations , 2014, World Journal of Surgery.

[38]  C. Reiners,et al.  Approach to the patient: role of dosimetric RAI Rx in children with DTC. , 2013, The Journal of clinical endocrinology and metabolism.

[39]  Jeffrey E. Lee,et al.  Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndrome. , 2013, Surgery.

[40]  M. Sibony,et al.  ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. , 2013, The New England journal of medicine.

[41]  C. Reid,et al.  Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. , 2013, Contemporary clinical trials.

[42]  E. Baudin,et al.  Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation. , 2013, European journal of endocrinology.

[43]  C. Spencer,et al.  Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[44]  C. Spencer.  Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement. , 2013, Thyroid : official journal of the American Thyroid Association.

[45]  L. Duntas,et al.  Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement. , 2013, Thyroid : official journal of the American Thyroid Association.

[46]  F. Beuschlein,et al.  Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. , 2013, The Journal of clinical endocrinology and metabolism.

[47]  S. Steinberg,et al.  Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma , 2013, Clinical Cancer Research.

[48]  S. Park,et al.  Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma. , 2013, Surgery.

[49]  H. Yamashita,et al.  Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence. , 2013, Endocrine journal.

[50]  E. Horváth-Puhó,et al.  Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. , 2013, The Journal of clinical endocrinology and metabolism.

[51]  A. Hoofnagle,et al.  Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry. , 2013, The Journal of clinical endocrinology and metabolism.

[52]  S. Larson,et al.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. , 2013, The New England journal of medicine.

[53]  R. Weil,et al.  Outcome of surgical treatment of 200 children with Cushing's disease. , 2013, The Journal of clinical endocrinology and metabolism.

[54]  W. Young,et al.  Massive Neonatal Adrenal Enlargement Due to Cytomegaly, Persistence of the Transient Cortex, and Hyperplasia of the Permanent Cortex: Findings in Cushing Syndrome Associated With Hemihypertrophy , 2012, The American journal of surgical pathology.

[55]  S. Larson,et al.  Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence. , 2012, Thyroid : official journal of the American Thyroid Association.

[56]  S. Baruchel,et al.  A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report , 2012, Clinical Cancer Research.

[57]  R. Tuttle,et al.  Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[58]  V. Lewington,et al.  Role of SPECT/CT in differentiated thyroid cancer , 2012, Nuclear medicine communications.

[59]  Tae Yong Kim,et al.  Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment. , 2012, Thyroid : official journal of the American Thyroid Association.

[60]  C. Stratakis,et al.  Anthropometric measures and fasting insulin levels in children before and after cure of Cushing syndrome. , 2012, Clinical nutrition.

[61]  T. Montesano,et al.  Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? , 2012, The Journal of clinical endocrinology and metabolism.

[62]  R. Ribeiro,et al.  The International Pediatric Adrenocortical Tumor Registry initiative: Contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors , 2012, Molecular and Cellular Endocrinology.

[63]  M. Fleseriu,et al.  Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[64]  C. Stratakis,et al.  Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease. , 2012, The Journal of clinical endocrinology and metabolism.

[65]  C. Spencer.  Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). , 2011, The Journal of clinical endocrinology and metabolism.

[66]  W. Young,et al.  Primary Bimorphic Adrenocortical Disease: Cause of Hypercortisolism in McCune-Albright Syndrome , 2011, The American journal of surgical pathology.

[67]  G. Cote,et al.  Management of medullary thyroid carcinoma and MEN2 syndromes in childhood , 2011, Nature Reviews Endocrinology.

[68]  A. Miyauchi,et al.  Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. , 2011, Thyroid : official journal of the American Thyroid Association.

[69]  C. Reiners,et al.  Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[70]  M. Gelfand,et al.  SPECT/CT imaging in children with papillary thyroid carcinoma , 2011, Pediatric Radiology.

[71]  D. Elashoff,et al.  Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review , 2011, Head & neck.

[72]  M. Luster,et al.  The use of dosimetry in the treatment of differentiated thyroid cancer. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[73]  M. Kreissl,et al.  Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[74]  R. Vigneri,et al.  Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. , 2011, The Journal of clinical endocrinology and metabolism.

[75]  R. Shamberger,et al.  Thyroid surgery at Children's Hospital Boston: a 35-year single-institution experience. , 2011, Journal of pediatric surgery.

[76]  A. Tabarin,et al.  Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines. , 2011, The Journal of clinical endocrinology and metabolism.

[77]  A. Bauer.  Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted? , 2011, The Journal of clinical endocrinology and metabolism.

[78]  Herb Chen,et al.  Evolution of pediatric thyroid surgery at a tertiary medical center. , 2011, The Journal of surgical research.

[79]  G. Cote,et al.  Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. , 2011, Thyroid : official journal of the American Thyroid Association.

[80]  D. van Nostrand,et al.  Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission? , 2011, Clinical endocrinology.

[81]  D. Zakalik,et al.  RET codon 804 mutations in multiple endocrine neoplasia 2: genotype–phenotype correlations and implications in clinical management , 2011, Clinical genetics.

[82]  F. Muntoni,et al.  Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. , 2010, The Journal of clinical investigation.

[83]  R. Kloos.  Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. , 2010, The Journal of clinical endocrinology and metabolism.

[84]  V. Bours,et al.  The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes , 2010, Clinical genetics.

[85]  S. Waguespack,et al.  Initial management and follow-up of differentiated thyroid cancer in children. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[86]  S. Rivkees.  Pediatric Graves’ Disease: Controversies in Management , 2010, Hormone Research in Paediatrics.

[87]  R. David,et al.  Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review. , 2010, Thyroid : official journal of the American Thyroid Association.

[88]  Q. Duh,et al.  Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. , 2010, Surgery.

[89]  R. Weiss,et al.  Approach to the patient with resistance to thyroid hormone and pregnancy. , 2010, The Journal of clinical endocrinology and metabolism.

[90]  F. Raue,et al.  Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC , 2010, Molecular and Cellular Endocrinology.

[91]  P. Singer,et al.  Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer. , 2010, Thyroid : official journal of the American Thyroid Association.

[92]  G. Mercuro,et al.  Early Markers of Cardiovascular Dysfunction in Young Girls Affected by Cushing's Syndrome before and after Successful Cure , 2010, Journal of pediatric endocrinology & metabolism : JPEM.

[93]  C. Stratakis,et al.  Effects of Cushing disease on bone mineral density in a pediatric population. , 2010, The Journal of pediatrics.

[94]  G. Mercuro,et al.  Increased arterial rigidity in children affected by Cushing’s syndrome after successful surgical cure , 2010, Cardiology in the Young.

[95]  N. Shah,et al.  Radiotherapy in paediatric Cushing’s disease: efficacy and long term follow up of pituitary function , 2010, Pituitary.

[96]  Rebecca J. Brown,et al.  Cushing syndrome in the McCune-Albright syndrome. , 2010, The Journal of clinical endocrinology and metabolism.

[97]  C. Zou,et al.  Childhood minimally invasive follicular carcinoma: Clinical features and immunohistochemistry analysis , 2010, Journal of paediatrics and child health.

[98]  Jaetae Lee,et al.  Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT , 2010, Clinical endocrinology.

[99]  Quan-Yong Luo,et al.  Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma. , 2010, Thyroid : official journal of the American Thyroid Association.

[100]  K. Khanna,et al.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). , 2009, The Journal of clinical endocrinology and metabolism.

[101]  P. Angelos.  Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. , 2009, The Surgical clinics of North America.

[102]  Stephanie L. Lee,et al.  Prediction of hypocalcemia after using 1‐ to 6‐hour postoperative parathyroid hormone and calcium levels: An analysis of pooled individual patient data from 3 observational studies , 2009, Head & neck.

[103]  R. Weiss,et al.  A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport. , 2009, Endocrinology.

[104]  Herb Chen,et al.  Outcomes of surgically managed pediatric thyroid cancer. , 2009, The Journal of surgical research.

[105]  C. Stratakis,et al.  Quality of life in children and adolescents 1‐year after cure of Cushing syndrome: a prospective study , 2009, Clinical endocrinology.

[106]  B. Edeiken,et al.  Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma , 2009, Head & neck.

[107]  T. Fahey,et al.  Ipsilateral Versus Bilateral Central Neck Lymph Node Dissection in Papillary Thyroid Carcinoma , 2009, Annals of surgery.

[108]  C. Stratakis,et al.  Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. , 2009, The Journal of clinical endocrinology and metabolism.

[109]  P. Angelos,et al.  Total thyroidectomy for benign disease in the pediatric patient--feasible and safe. , 2009, Journal of pediatric surgery.

[110]  E. Oldfield,et al.  Postoperative testing to predict recurrent Cushing disease in children. , 2009, The Journal of clinical endocrinology and metabolism.

[111]  Shu-ye Yang,et al.  Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis , 2009, Nuclear medicine communications.

[112]  M. Charron,et al.  Radioiodine treatment of juvenile Graves disease. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[113]  K. Lorenz,et al.  Constitutive RET tyrosine kinase activation in hereditary medullary thyroid cancer: clinical opportunities , 2009, Journal of internal medicine.

[114]  C. Grant,et al.  Operative technique for modified radical neck dissection in papillary thyroid carcinoma. , 2009, Archives of surgery.

[115]  H. Gharib,et al.  Medullary thyroid cancer: management guidelines of the American Thyroid Association. , 2009, Thyroid : official journal of the American Thyroid Association.

[116]  N. Patronas,et al.  Blood pressure in pediatric patients with Cushing syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[117]  Jacques Young,et al.  The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits. , 2009, The Journal of clinical endocrinology and metabolism.

[118]  B. Niederle,et al.  Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region: A Prospectively Collected, Retrospectively Analyzed Clinical Trial , 2009, Annals of surgery.

[119]  J. Hugot,et al.  Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. , 2009, European journal of endocrinology.

[120]  Rong Mao,et al.  Multiple endocrine neoplasia type 2 RET protooncogene database: Repository of MEN2‐associated RET sequence variation and reference for genotype/phenotype correlations , 2009, Human mutation.

[121]  Michelle D. Williams,et al.  The successful use of sorafenib to treat pediatric papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[122]  S. Roman,et al.  Pediatric endocrine surgery: who is operating on our children? , 2008, Surgery.

[123]  S. Hess,et al.  Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. , 2008, Surgery.

[124]  Tae Yong Kim,et al.  Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.

[125]  C. Stratakis,et al.  Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[126]  M. Uchiyama,et al.  Mutation of a gene for thyroid transcription factor-1 (TITF1) in a patient with clinical features of resistance to thyrotropin. , 2008, Endocrine journal.

[127]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[128]  S. Larson,et al.  Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal , 2008, Journal of Nuclear Medicine.

[129]  E. Kebebew.  Hereditary Non-medullary Thyroid Cancer , 2008, World Journal of Surgery.

[130]  R. Weber,et al.  Recent advances in thyroid cancer. , 2008, Current problems in surgery.

[131]  C. Stratakis,et al.  Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. , 2008, The New England journal of medicine.

[132]  J. Tward,et al.  The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. , 2008, The Journal of clinical endocrinology and metabolism.

[133]  E. Baudin,et al.  Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. , 2008, European journal of endocrinology.

[134]  F. Savagner,et al.  A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation: a 20-year follow-up. , 2008, Thyroid : official journal of the American Thyroid Association.

[135]  Yong-xue Zhu,et al.  Long-term impact of initial surgical and medical therapy on young patients with papillary thyroid cancer and bilateral cervical metastases. , 2008, Chinese medical journal.

[136]  S. Larson,et al.  Radioactive iodine therapy in poorly differentiated thyroid cancer , 2007, Nature Clinical Practice Oncology.

[137]  E. Baudin,et al.  Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. , 2007, The Journal of clinical endocrinology and metabolism.

[138]  L. Freudenberg,et al.  Thyroid cancer in childhood: management strategy, including dosimetry and long-term results. , 2007, Hormones.

[139]  C. Stratakis,et al.  Diagnostic Tests for Children Who Are Referred for the Investigation of Cushing Syndrome , 2007, Pediatrics.

[140]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[141]  S. Mandel,et al.  Therapy Insight: management of Graves' disease during pregnancy , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[142]  B. Jarzab,et al.  Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer , 2007, Journal of Nuclear Medicine.

[143]  S. Sidhu,et al.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. , 2006, Surgery.

[144]  A. Popovtzer,et al.  Thyroid Cancer in Children: Management and Outcome Experience of a Referral Center , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[145]  S. Larson,et al.  Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[146]  K. Millen,et al.  Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. , 2006, Endocrinology.

[147]  H. Buhr,et al.  Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. , 2006, European journal of endocrinology.

[148]  I. Bossis,et al.  A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia , 2006, Nature Genetics.

[149]  W. Wiersinga,et al.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.

[150]  Hanna Göransson,et al.  Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors , 2006, Tumor Biology.

[151]  C. Reiners,et al.  Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus , 2006, Annals of surgery.

[152]  A. Stojadinovic,et al.  The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. , 2006, Thyroid : official journal of the American Thyroid Association.

[153]  C. Larsson,et al.  The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion. , 2006, The Journal of clinical endocrinology and metabolism.

[154]  Mithat Gonen,et al.  Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. , 2006, The Journal of clinical endocrinology and metabolism.

[155]  B. Jarzab,et al.  Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. , 2005, Endocrine-related cancer.

[156]  L. Nieman,et al.  Cushing's syndrome , 2005 .

[157]  C. Cowell,et al.  The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children. , 2005, Journal of pediatric surgery.

[158]  B. Biondi,et al.  Thyroid-hormone therapy and thyroid cancer: a reassessment , 2005, Nature Clinical Practice Endocrinology &Metabolism.

[159]  Stephen A. Huang,et al.  Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal. , 2005, The Journal of clinical endocrinology and metabolism.

[160]  L. Schomburg,et al.  Mutations in SECISBP2 result in abnormal thyroid hormone metabolism , 2005, Nature Genetics.

[161]  P. Froguel,et al.  Identification of a locus for nongoitrous congenital hypothyroidism on chromosome 15q25.3-26.1 , 2005, Human Genetics.

[162]  K. Owzar,et al.  Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.

[163]  E. Oldfield,et al.  Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease. , 2005, The Journal of clinical endocrinology and metabolism.

[164]  T. Visser,et al.  Thyroid hormone transporters in health and disease. , 2005, Thyroid : official journal of the American Thyroid Association.

[165]  Brian A Palmer,et al.  Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence. , 2005, Journal of pediatric surgery.

[166]  P. Macchia,et al.  Autosomal dominant resistance to thyrotropin as a distinct entity in five multigenerational kindreds: clinical characterization and exclusion of candidate loci. , 2005, The Journal of clinical endocrinology and metabolism.

[167]  S. Giovanni,et al.  Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: Response to 12- month triiodothyroacetic acid (TRIAC) therapy , 2005, Journal of endocrinological investigation.

[168]  M. Abramowicz,et al.  Thyroid transcription factor 1 rescues PAX8/p300 synergism impaired by a natural PAX8 paired domain mutation with dominant negative activity. , 2005, Molecular endocrinology.

[169]  A. Bockisch,et al.  Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. , 2005, European journal of endocrinology.

[170]  J. Livezey,et al.  BRAF mutations are uncommon in papillary thyroid cancer of young patients. , 2005, Thyroid : official journal of the American Thyroid Association.

[171]  J. Giedd,et al.  Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[172]  H. Storr,et al.  Final adult height and body mass index after cure of paediatric Cushing's disease , 2005, Clinical endocrinology.

[173]  Jie Liu,et al.  Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2004-0865 Minireview: GNAS: Normal and Abnormal Functions , 2022 .

[174]  C. Sekulla,et al.  Multiple Endocrine Neoplasia 2B Syndrome due to Codon 918 Mutation: Clinical Manifestation and Course in Early and Late Onset Disease , 2004, World Journal of Surgery.

[175]  G. Thompson,et al.  Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma , 2004, World Journal of Surgery.

[176]  L. Duntas,et al.  Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. , 2004, European journal of endocrinology.

[177]  N. Berger,et al.  Predictive Factors for Recurrence from a Series of 74 Children and Adolescents with Differentiated Thyroid Cancer , 2004, World Journal of Surgery.

[178]  A. Uitterlinden,et al.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.

[179]  M. Tansey,et al.  A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. , 2004, The Journal of clinical endocrinology and metabolism.

[180]  N. Eberhardt,et al.  The PAX8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma. , 2004, Current drug targets. Immune, endocrine and metabolic disorders.

[181]  Dingcai Cao,et al.  Fetal loss associated with excess thyroid hormone exposure. , 2004, JAMA.

[182]  J. Shah,et al.  Follicular variant of papillary thyroid carcinoma: Genome‐wide appraisal of a controversial entity , 2004, Genes, chromosomes & cancer.

[183]  H. V. van Santen,et al.  Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. , 2004, European journal of cancer.

[184]  C. Stratakis,et al.  Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? , 2004, The Journal of clinical endocrinology and metabolism.

[185]  W. Mendenhall,et al.  Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine , 2004, Pediatric blood & cancer.

[186]  J. Kalinyak,et al.  Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans , 2004, Nuclear medicine communications.

[187]  Bruno D Fornage,et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.

[188]  E. Vignali,et al.  Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens , 2003, Annals of Internal Medicine.

[189]  A. Pinchera,et al.  Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[190]  E. Ferrannini,et al.  Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer. , 2003, Thyroid : official journal of the American Thyroid Association.

[191]  Stephanie L. Lee,et al.  A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.

[192]  J. Vijungco,et al.  Greater Local Recurrence Occurs with “Berry Picking” than Neck Dissection in Thyroid Cancer , 2003, The American surgeon.

[193]  E. Baudin,et al.  Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. , 2003, The Journal of clinical endocrinology and metabolism.

[194]  G. Blair,et al.  Pediatric surgical images: PET evaluation of papillary thyroid carcinoma recurrence. , 2002, Journal of pediatric surgery.

[195]  P. Grigsby,et al.  Childhood and adolescent thyroid carcinoma , 2002, Cancer.

[196]  N. Sarlis,et al.  Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. , 2002, Thyroid : official journal of the American Thyroid Association.

[197]  S. Larson,et al.  Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? , 2002, The Journal of clinical endocrinology and metabolism.

[198]  J. Romijn,et al.  Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma? , 2002, Clinical endocrinology.

[199]  P. Larsen,et al.  High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.

[200]  G. Chrousos,et al.  Cushing’s syndrome in children and adolescents: Current diagnostic and therapeutic strategies , 2002, Journal of endocrinological investigation.

[201]  B. Ponder,et al.  Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.

[202]  R. Kloos,et al.  Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer , 2001 .

[203]  N. Freimer,et al.  Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. , 2000, Surgery.

[204]  D. Farley,et al.  Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. , 2000, Surgery.

[205]  R. A. Decker,et al.  Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated? , 2000, Surgery.

[206]  S. Filetti,et al.  A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. , 2000, The Journal of clinical endocrinology and metabolism.

[207]  A. Grossman,et al.  Linear growth and final height after treatment for Cushing's disease in childhood. , 2000, The Journal of clinical endocrinology and metabolism.

[208]  C. Stratakis,et al.  Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex , 2000, Nature Genetics.

[209]  J. Hurley,et al.  Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[210]  N. Thompson,et al.  Complications of Thyroid Surgery: How to Avoid Them, How to Manage Them, and Observations on Their Possible Effect on the Whole Patient , 2000, World Journal of Surgery.

[211]  B. Jarzab,et al.  Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children , 2000, European Journal of Nuclear Medicine.

[212]  B. Nygaard,et al.  Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values , 2000, European Journal of Clinical Nutrition.

[213]  A. Pinchera,et al.  Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. , 2000, The Journal of clinical endocrinology and metabolism.

[214]  R. Tuttle,et al.  The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. , 2000, The Journal of clinical endocrinology and metabolism.

[215]  D. Robie,et al.  Extensive surgery improves recurrence-free survival for children and young patients with class I papillary thyroid carcinoma. , 1999, Journal of pediatric surgery.

[216]  C. Stratakis,et al.  Adrenocortical Tumors: Recent Advances in Basic Concepts and Clinical Management , 1999, Annals of Internal Medicine.

[217]  P. Ladenson,et al.  Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma , 1998, Annals of Internal Medicine.

[218]  N. Powe,et al.  The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. , 1998, Annals of surgery.

[219]  A. Samuel,et al.  Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[220]  R. Hinze,et al.  Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.

[221]  I. Hughes,et al.  Radioiodine Treatment of Graves’ Disease in Young People , 1998, Hormone Research in Paediatrics.

[222]  J. Parma,et al.  Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? , 1998, The Journal of clinical endocrinology and metabolism.

[223]  P. Singer,et al.  Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. , 1998, The Journal of clinical endocrinology and metabolism.

[224]  C. Sklar,et al.  Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. , 1998, Annals of surgery.

[225]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[226]  M. Nardi,et al.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. , 1998, The New England journal of medicine.

[227]  Jun Xie,et al.  Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. , 1997, The Journal of clinical endocrinology and metabolism.

[228]  T. Gudermann,et al.  Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. , 1997, The Journal of clinical endocrinology and metabolism.

[229]  John H. T. Waldhausen.  Controversies related to the medical and surgical management of hyperthyroidism in children. , 1997, Seminars in pediatric surgery.

[230]  J. Parma,et al.  Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. , 1997, The Journal of clinical investigation.

[231]  M. Dottorini,et al.  Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[232]  P. Beck‐Peccoz,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Two Novel Mutations in the Thyrotropin (TSH) Receptor Gene in a Child with Resistance to TSH* , 2022 .

[233]  E. Milgrom,et al.  Four families with loss of function mutations of the thyrotropin receptor. , 1996, The Journal of clinical endocrinology and metabolism.

[234]  C Eng,et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.

[235]  J. Söreide,et al.  Surgical Treatment of Graves’ Disease in Patients Younger than 18 Years , 1996, World Journal of Surgery.

[236]  H. Gharib,et al.  Multiple endocrine neoplasia type 2B: more than an endocrine disorder. , 1995, Surgery.

[237]  R. Koshida,et al.  Central hypothyroidism resulting from pituitary suppression and peripheral thyrotoxicosis in a premature infant born to a mother with Graves disease. , 1995, The Journal of pediatrics.

[238]  U. Feldt-Rasmussen,et al.  Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. , 1995, Thyroid : official journal of the American Thyroid Association.

[239]  M. Gelfand,et al.  Iodine-131 therapy of hyperthyroidism in pediatric patients. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[240]  Y. Hayashi,et al.  Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. , 1995, The New England journal of medicine.

[241]  G. Chrousos,et al.  Final stature in patients with endogenous Cushing's syndrome. , 1994, The Journal of clinical endocrinology and metabolism.

[242]  J. Doppman,et al.  Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. , 1994, The New England journal of medicine.

[243]  Y. Harihara,et al.  Blood supply of the parathyroid gland from the superior thyroid artery. , 1994, Surgery.

[244]  P. Goodfellow,et al.  Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[245]  R. Hofstra,et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.

[246]  P. Goodfellow,et al.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. , 1993, Human molecular genetics.

[247]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[248]  V. S. Kazakov,et al.  Thyroid cancer after Chernobyl , 1992, Nature.

[249]  J. Doppman,et al.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. , 1991, The New England journal of medicine.

[250]  R. Hoover,et al.  Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. , 1991, Cancer research.

[251]  R. Berger,et al.  Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31. , 1990, Genomics.

[252]  G. Chrousos,et al.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. , 1984, The New England journal of medicine.

[253]  J. Mckenzie,et al.  Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.

[254]  J. Carney,et al.  Multiple endocrine neoplasia with skeletal manifestations. , 1981, The Journal of bone and joint surgery. American volume.

[255]  E. Kaplan,et al.  Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. , 1975, The New England journal of medicine.

[256]  A. Tashjian,et al.  C-cell hyperplasia preceding medullary thyroid carcinoma. , 1973, The New England journal of medicine.

[257]  P. Rocmans,et al.  Congenital hypothyroidism with impaired thyroid response to thyrotropin. , 1968, The New England journal of medicine.

[258]  N. Patronas,et al.  Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. , 2015, The Journal of clinical endocrinology and metabolism.

[259]  Z. Baloch,et al.  C-Cells and their Associated Lesions and Conditions: A Pathologists Perspective. , 2015, Turk patoloji dergisi.

[260]  M. Cabanillas,et al.  The treatment landscape in thyroid cancer : a focus on cabozantinib , 2015 .

[261]  F. Raue,et al.  Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. , 2015, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[262]  J. R. Mayer,et al.  Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation. , 2014, Thyroid : official journal of the American Thyroid Association.

[263]  M. Hirokawa,et al.  Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups. , 2014, Endocrine journal.

[264]  K. Martin,et al.  Management of Thyroid Dysfunction During Pregnancy and Postpartum , 2013 .

[265]  T. Fahey.  Long-Term Outcome of Comprehensive Central Compartment Dissection in Patients with Recurrent/Persistent Papillary Thyroid Carcinoma , 2012 .

[266]  Douglas B. Evans,et al.  Ultrasonography Should Not Guide the Timing of Thyroidectomy in Pediatric Patients Diagnosed with Multiple Endocrine Neoplasia Syndrome 2A through Genetic Screening , 2012, Annals of Surgical Oncology.

[267]  I. Apostolova,et al.  Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan? , 2011, Annals of Nuclear Medicine.

[268]  C. Stratakis.  Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome). , 2008, Endocrine development.

[269]  T. Pilli,et al.  Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. , 2008, The Journal of clinical endocrinology and metabolism.

[270]  Jeffrey E. Lee,et al.  Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think? , 2007, Annals of Surgical Oncology.

[271]  E. Oldfield,et al.  An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. , 2006, The Journal of clinical endocrinology and metabolism.

[272]  A. Di Giorgio,et al.  Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[273]  Katherine A. Drake,et al.  Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRbeta(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormone. , 2005, Bioorganic & medicinal chemistry.

[274]  R. Kloos,et al.  A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. , 2005, The Journal of clinical endocrinology and metabolism.

[275]  K. Brockmann,et al.  A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. , 2004, American journal of human genetics.

[276]  C. Stratakis,et al.  Clinical and Genetic Analysis of Primary Bilateral Adrenal Diseases (Micro- and Macronodular Disease) Leading to Cushing Syndrome , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[277]  B. Rapoport,et al.  The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. , 1998, Endocrine reviews.

[278]  G. Moll,et al.  Pediatric Graves' Disease: Therapeutic Options and Experience With Radioiodine at the University of Mississippi Medical Center , 1997, Southern medical journal.

[279]  C. Tsigos,et al.  Differential diagnosis and management of Cushing's syndrome. , 1996, Annual review of medicine.

[280]  Y. Nikiforov,et al.  Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. , 1996, The Journal of clinical endocrinology and metabolism.

[281]  Ajay Mahaputra Kumar,et al.  Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. , 1994, Thyroid : official journal of the American Thyroid Association.

[282]  J. Mckenzie,et al.  Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. , 1992, Thyroid : official journal of the American Thyroid Association.

[283]  M. Mattei,et al.  Localization of human thyrotropin receptor gene to chromosome region 14q3 by in situ hybridization. , 1990, Cytogenetics and cell genetics.

[284]  C. Dufourmentel.  [THYROID CANCER IN CHILDREN]. , 1965, L'Annee endocrinologique.

[285]  M. Sonenberg,et al.  The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.